Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ALNY - Alnylam Pharmaceuticals reports Q3 earnings miss; reaffirms FY22 guidance

ALNY - Alnylam Pharmaceuticals reports Q3 earnings miss; reaffirms FY22 guidance

Alnylam Pharmaceuticals Inc.
  • Alnylam Pharmaceuticals press release ( NASDAQ: ALNY ): Q3 Non-GAAP EPS of -$1.58 misses by $0.20 .
  • Revenue of $264.31M (+40.9% Y/Y) misses by $27.35M .
  • Cash, cash equivalents and marketable securities were $2.27B as of September 30, 2022 compared to $2.44B as of December 31, 2021.
  • Reiterated 2022 Combined Net Product Revenue Guidance of $870-$930 Million

For further details see:

Alnylam Pharmaceuticals reports Q3 earnings miss; reaffirms FY22 guidance
Stock Information
Company Name: Alnylam Pharmaceuticals Inc.
Stock Symbol: ALNY
Market: NASDAQ
Website: alnylam.com
Menu
ALNY ALNY Quote ALNY Short ALNY News ALNY Articles ALNY Message Board
Get ALNY Alerts

News, Short Squeeze, Breakout and More Instantly...